HC Wainwright Has Negative Forecast for NMRA Q2 Earnings
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) – Stock analysts at HC Wainwright reduced their Q2 2025 earnings estimates for Neumora Therapeutics in a research note issued on Tuesday, May 13th. HC Wainwright analyst D. Tsao now expects that the company will post earnings per share of ($0.44) for the quarter, down from their previous […]
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) – Stock analysts at HC Wainwright reduced their Q2 2025 earnings estimates for Neumora Therapeutics in a research note issued on Tuesday, May 13th. HC Wainwright analyst D. Tsao now expects that the company will post earnings per share of ($0.44) for the quarter, down from their previous […]
